4.7 Article

Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa

期刊

JOURNAL OF CLINICAL MICROBIOLOGY
卷 50, 期 2, 页码 525-527

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.05956-11

关键词

-

资金

  1. Merck
  2. Sanofi-Aventis
  3. Pfizer
  4. MSD
  5. BMS
  6. Astra-Zeneca
  7. Roche
  8. Winthrop
  9. Aspen
  10. Bayer
  11. GSK
  12. Janssen
  13. Fresenius Kabi
  14. Abbott

向作者/读者索取更多资源

This report documents emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in K. pneumoniae and Enterobacter cloacae in South Africa. NDM-1 producers have not been described in South Africa, and this is the first instance that KPC producers have been identified in Africa. The two patients infected with these carbapenemase-producing bacteria demised.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据